Implementing Minoritized Community Engagement with Pediatric Dermatology

Dermatology care is nearly non-existent for American Indian and Alaska Native (AIAN) youth. The Indian Health Service (IHS) currently employs a single dermatologist for more than 2 million patients, which suggests that AIAN youth face substantial barriers to accessing dermatology. Limited treatment for skin disease may explain health disparities in prevalence and severity of skin disease among AIAN youth compared to the general United States (US) youth population. The consequences of such disparities are well-established. Skin disease has significant and long-term impacts on affected youth and their families. For example, untreated skin diseases among youth populations are associated with poorer quality of life, sleep disruptions, learning difficulties, mood disorders, and school absenteeism. The short-term goal of this study is to obtain actionable evidence regarding AIAN youths’ access to dermatology care by analyzing a national healthcare database and through AIAN stakeholder interviews.

Clinical Outcomes by Language of Care in Pediatric Oncology

Although language disparities in outcomes are well documented in general pediatrics and adult oncology, little is known in pediatric oncology. Patient or family language is not included in many multi- institutional databases and patient registries, limiting studies of language-based inequities…

Extreme weather impacts on children’s acute and chronic health outcomes; a multisite study with evaluation of vulnerabilities

The “Extreme Weather and Pediatric Health Outcomes” study investigates the impact of climate change-related extreme weather events, such as extreme heat and heavy rainfall, on children’s health across the United States. This innovative research aims to address critical knowledge gaps…

Characterization of Babies Born with Hemolytic Disease of the Fetus/Newborn (HDFN)

Hemolytic disease of the fetus and newborn (HDFN) otherwise known as erythroblastosis fetalis, is a disease in which fetal and neonatal erythrocytes are destroyed by maternal IgG alloantibodies. Before the first RhD immunoprophylaxis was introduced as a treatment in 1968,…

Scroll to Top